Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
Open Access
- 19 November 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Health Services Research
- Vol. 12 (1), 408
- https://doi.org/10.1186/1472-6963-12-408
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- European countries with small populations can obtain low prices for drugs: Lithuania as a case historyExpert Review of Pharmacoeconomics & Outcomes Research, 2011
- Policies to Enhance Prescribing Efficiency in Europe: Findings and Future ImplicationsFrontiers in Pharmacology, 2011
- Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implicationsExpert Review of Pharmacoeconomics & Outcomes Research, 2010
- Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implicationsExpert Review of Pharmacoeconomics & Outcomes Research, 2010
- Acid-Suppressive Medication Use and the Risk for Hospital-Acquired PneumoniaJAMA, 2009
- Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevanceExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- Overprescribing proton pump inhibitorsBMJ, 2008
- Use of Proton Pump Inhibitors and the Risk of Community-Acquired PneumoniaArchives of Internal Medicine, 2007
- Inappropriate prescribing of proton pump inhibitors in primary carePublished by Oxford University Press (OUP) ,2007
- Reducing community dyspepsia drug costs: a controlled trialGut, 2001